Ozempic vs Wegovy in Korea: What’s the Difference?

Ozempic and Wegovy are often discussed together because both contain semaglutide, a GLP-1 receptor agonist. However, in Korea, they are not used in exactly the same way. The biggest difference is that Ozempic is primarily a type 2 diabetes medication, while Wegovy is approved for obesity and weight management. Korean reporting also describes Ozempic as a diabetes injection with the same active ingredient as Wegovy.

For foreigners in Korea, understanding the difference is important before booking a consultation. Even though both medications may affect appetite and weight, the prescription purpose, eligibility, insurance status, dosage plan, and clinic approach can be different.

✔️ What Is Ozempic?

Ozempic is a semaglutide-based injectable medication mainly used for type 2 diabetes management. It helps improve blood sugar control and may also lead to weight loss in some patients, but it is not generally treated as a simple weight loss drug.

In Korea, Ozempic has been connected to stricter reimbursement and prescribing rules because authorities are trying to prevent diabetes medication from being used mainly as a cheaper substitute for obesity treatment. Public reporting in February 2026 noted that Korea began reimbursing Ozempic for certain diabetes patients under defined criteria.

Ozempic may be considered for patients who need:

• Type 2 diabetes treatment
• Blood sugar control support
• Doctor-supervised metabolic care
• A diabetes-focused GLP-1 treatment plan
• Medical monitoring based on blood glucose and related health risks

For foreigners, Ozempic should be discussed with a doctor if there is a real diabetes-related medical need, not only a desire for weight loss.

✔️ What Is Wegovy?

Wegovy is also a semaglutide-based injectable medication, but it is designed and approved for weight loss and long-term weight management. In Korea, Wegovy was approved for adults with BMI 30 or higher, or BMI 27 to under 30 with at least one weight-related condition, and it launched in South Korea in October 2024.

Wegovy is used together with:

• Reduced-calorie diet
• Increased physical activity
• Medical weight management
• Regular follow-up care
• Long-term lifestyle planning

Unlike Ozempic, Wegovy is more directly connected to obesity treatment and weight management programs.

✔️ Main Difference Between Ozempic and Wegovy

The main difference is not just the ingredient. Both medications contain semaglutide, but they are generally used for different medical goals.

• Ozempic: Mainly for type 2 diabetes
• Wegovy: Mainly for obesity and weight management
• Ozempic goal: Blood sugar and metabolic control
• Wegovy goal: Weight loss and weight maintenance
• Ozempic consultation: Diabetes-focused medical evaluation
• Wegovy consultation: Obesity and body weight management evaluation
• Ozempic access in Korea: More closely tied to diabetes criteria and reimbursement rules
• Wegovy access in Korea: Usually accessed as an obesity treatment through prescription-based medical care

Wegovy is available in several dose strengths and is typically titrated from a lower weekly dose toward a maintenance dose under medical supervision. Korean medical reporting described Wegovy as a once-weekly obesity injection with five dose levels: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg.

✔️ Which One Is Better for Weight Loss in Korea?

For foreigners specifically looking for medical weight loss in Korea, Wegovy is usually the more relevant option because it is approved for obesity treatment and weight management.

Ozempic may still lead to weight loss in some patients, but it is primarily a diabetes medication. In Korea, using Ozempic only for cosmetic or non-diabetes weight loss may be difficult and may not match the intended prescription purpose.

Wegovy may be more suitable for patients who:

• Meet the BMI or weight-related health criteria
• Want a doctor-supervised weight loss plan
• Need support with appetite control
• Prefer a structured medical weight management program
• Can commit to follow-up visits and lifestyle changes

The right option depends on your medical history, BMI, diabetes status, current medications, and treatment goals.

✔️ Cost and Insurance Differences

Cost is another major difference. In Korea, Ozempic may be connected to national health insurance reimbursement for certain eligible type 2 diabetes patients under specific criteria. Wegovy, on the other hand, has been reported as an uninsured obesity treatment, meaning final patient prices may vary depending on the healthcare provider and dispensing process.

Foreigners should ask clearly about:

• Consultation fees
• Medication cost
• Prescription and pharmacy process
• Follow-up visit cost
• Whether body analysis is included
• Total monthly estimate
• Insurance or self-pay status

Because prices and availability can change, it is best to confirm directly during consultation before starting treatment.

✔️ Safety Information for Foreigners

Both Ozempic and Wegovy should only be used under medical supervision. They are prescription medications, not casual diet products. The Korean Novo Nordisk product page also warns that prescription medicines should not be purchased online and that Wegovy should be used according to approved instructions.

Possible side effects may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Indigestion
• Stomach discomfort
• Reduced appetite
• Headache
• Gallbladder-related concerns
• Rare but serious pancreas-related risks

Foreign patients should tell the doctor about any history of diabetes, thyroid disease, pancreatitis, gallbladder disease, kidney problems, pregnancy plans, breastfeeding, or current medication use.

✔️ What to Expect During a Consultation in Korea

A consultation for Ozempic or Wegovy will usually include a review of your medical background, BMI, lifestyle, current medications, and treatment goal. The focus may differ depending on which medication is being considered.

For Ozempic, the doctor may focus more on:

• Blood sugar levels
• Diabetes history
• Current diabetes medications
• Cardiometabolic risk factors
• Insurance eligibility or reimbursement criteria

For Wegovy, the doctor may focus more on:

• BMI and body composition
• Weight-related health conditions
• Previous weight loss attempts
• Diet and exercise habits
• Dose schedule and follow-up plan

A foreigner-friendly clinic should explain the difference clearly and recommend treatment based on medical suitability, not just popularity.

✔️ Which One Should Foreigners Ask About?

Foreigners should ask about Wegovy if their main goal is medically supervised weight loss and they meet obesity-related criteria.

Foreigners should ask about Ozempic if they have type 2 diabetes or diabetes-related medical concerns and want to discuss blood sugar management with a doctor.

Before choosing either option, prepare:

• Your height, weight, and BMI
• Any diabetes diagnosis or blood test results
• A list of current medications
• Your medical history
• Previous weight loss treatments
• Your expected stay in Korea
• Questions about cost, dosage, side effects, and follow-up

This helps the doctor choose a safer and more appropriate plan.

✔️ Final Thoughts

Ozempic and Wegovy may sound similar because they both contain semaglutide, but their purpose in Korea is different. Ozempic is mainly for type 2 diabetes, while Wegovy is designed for obesity and weight management.

For foreigners seeking weight loss care in Korea, Wegovy is usually the more relevant medication to ask about. However, both medications require a proper prescription, medical evaluation, and follow-up care. The safest choice is to visit a foreigner-friendly clinic that provides clear communication, transparent pricing, realistic guidance, and doctor-led treatment planning.